Novo Nordisk A S NVO Cash Flow Statement (2012-2017)

NYSE NVO
$39.15 +0.86 (+2.25%)
At close: Oct 29, 2026 · 4:00 PM EDT
Reported Financials

Novo Nordisk A S Quarterly Cash Flow Statement

Periods 24 quarters
Latest Dec 2017

Novo Nordisk A S reported cash from operations of $0.99B and free cash flow of $0.52B for the quarter ended Dec 2017, down 38.7% year over year. This cash flow statement covers 24 quarters of results from Mar 2012 through Dec 2017, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017
Operating Activities
Net Income
1,059.00M1,181.00M1,139.00M1,105.00M1,185.00M1,286.00M1,153.00M26,481.00M1,492.00M1,231.00M1,249.00M1,210.00M1,396.00M1,511.00M1,470.00M1,256.00M1,454.00M1,470.00M1,538.00M1,314.00M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
122.00M119.00M114.00M2,799.00M121.00M122.00M212.00M3,435.00M100.00M96.00M94.00M150.00M92.00M109.00M110.00M163.00M101.00M127.00M112.00M142.00M
Other non-cash itemsOther Non-Cash
584.00M4,163.00M
Change in Working Capital
2,148.00M
Change in Other Operating AssetsOther Assets Change
70,337.00M77,062.00M91,799.00M97,539.00M
Other Working Capital ChangesOther WC Changes
-70,337.00M-77,062.00M-91,799.00M-97,539.00M
Other Operating Activities (as filed)
131.00M
Cash from OperationsCash from Ops.
1,251.00M1,277.00M1,105.00M986.00M747.00M1,493.00M2,191.00M31,692.00M620.00M1,784.00M1,802.00M1,485.00M1,104.00M2,184.00M2,277.00M1,611.00M1,732.00M1,499.00M2,017.00M988.00M
Investing Activities
Capital ExpendituresCapex
138.00M137.00M161.00M135.00M127.00M148.00M176.00M3,990.00M115.00M151.00M186.00M322.00M161.00M254.00M268.00M366.00M230.00M285.00M327.00M473.00M
Sales of Property, Plant and EquipmentPP&E (Sale)
4.00M
Change in Property, Plant and EquipmentChange in PP&E
-138.00M-137.00M-161.00M-135.00M-127.00M-148.00M-176.00M-3,986.00M-115.00M-151.00M-186.00M-322.00M-161.00M-254.00M-268.00M-366.00M-230.00M-285.00M-327.00M-473.00M
Change in IntangiblesChange Intangibless
321.00M
Divestments
359.00M
Net of Acquisitions & DivestmentsNet Acquisitions
359.00M
Purchase of InvestmentsInvestments Purchased
24.00M
Sale and Maturity of InvestmentsInvestments Sold
2,232.00M
Other Investing Activities (as filed)Other investing (as filed)
35.00M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
42,569.00M40,294.00M46,969.00M45,269.00M
Net Shares Issued and RepurchasedNet Shares Issued
42,569.00M14,667.00M17,196.00M45,269.00M
Net Equity Issued and RepurchasedNet Equity Issued
42,569.00M14,667.00M17,196.00M45,269.00M
Dividend Payments
Dividends Paid - Common and PreferredDiv Paid (Total)
11,866.00M
Cash from Financing ActivitiesCash from Financing
26,533.00M
Additional items
Exchange Rate EffectFX Effect
68.00M
Change in Cash
1,094.00M1,126.00M927.00M834.00M601.00M1,332.00M2,005.00M27,396.00M853.00M1,609.00M1,611.00M1,014.00M939.00M1,920.00M1,874.00M39,991.00M1,489.00M1,244.00M1,706.00M497.00M
Ending Cash Balance
13,676.00M15,850.00M18,461.00M
Free Cash FlowFCF
1,113.00M1,140.00M944.00M851.00M620.00M1,345.00M2,015.00M27,702.00M505.00M1,633.00M1,616.00M1,163.00M943.00M1,930.00M2,009.00M1,245.00M1,502.00M1,214.00M1,690.00M515.00M
Net Cash FlowNCF
1,251.00M1,277.00M1,105.00M986.00M747.00M1,493.00M2,191.00M58,225.00M620.00M1,784.00M1,802.00M1,485.00M1,104.00M2,184.00M2,277.00M1,611.00M1,732.00M1,499.00M2,017.00M988.00M
Interest Paid
78.00M
Income Taxes PaidTaxes Paid
7,355.00M7,907.00M

Novo Nordisk A S Cash Flow Statement API

Pull Novo Nordisk A S's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NVO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY